Kamal Pohar S MD


Kamal Pohar S MD
Assoc ProfessorCollege of Medicinepohar.1@osu.edu
Olentangy River Road 915 915 Olentangy River Road Columbus Ohio 43212
Phone:614-293-4885Fax: (614) 293-3565
  • Molecular Biology and Cancer Genetics

Research Description

Dr. Pohar’s research interest include: Bladder cancer, Testicular cancer, Genetic and epigenetic changes contributing to progression of bladder cancer, and Developing clinical and biologic databases in bladder cancer.

Current Publications

  • Nguyen HT, Jia G, Shah ZK, Pohar K, Mortazavi A, Zynger DL, Wei L, Yang X, Clark D, Knopp MVPrediction of chemotherapeutic response in bladder cancer using K-means clustering of dynamic contrast-enhanced (DCE)-MRI pharmacokinetic parameters.J Magn Reson Imaging in press 6/19/2014
  • Knopp MV, Nguyen HT, Pohar KS, Jia G, Shah ZK, Mortazavi A, Zynger DL, Wei L, Clark D, Yang XImproving bladder cancer imaging using 3-T functional dynamic contrast-enhanced magnetic resonance imaging.Invest Radiol 49 390-5 6/1/2014
  • Perrino CM, Fichtenbaum EJ, Pohar KS, Zynger DLChallenges in the pathological reporting of urothelial carcinoma involving prostatic transurethral resection specimens within a single institution.Pathology 45 664-9 12/1/2013
  • D'Souza AM, Phillips GS, Pohar KS, Zynger DLClinicopathologic characteristics and overall survival in patients with bladder cancer involving the gastrointestinal tract.Virchows Arch 463 811-8 12/1/2013
  • Pohar KSThe anatomic extent and completeness of pelvic lymphadenectomy is what matters.Curr Opin Urol 23 444-8 9/1/2013
  • Inman BA, Kuban DA, Kuzel TM, Lele SM, Michalski J, Pagliaro L, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Richie JP, Sexton WJ, Shipley WU, Small EJ, Clark PE, Spiess PE, Agarwal N, Biagioli MC, Eisenberger MA, Greenberg RE, Herr HW, Trump DL, Wile G, Wilson TG, Dwyer M, Ho M, National Comprehensive Cancer NetworkPenile cancer: Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw 11 594-615 5/1/2013
  • Sexton WJ, Shipley WU, Small EJ, Spiess PE, Trump DL, Wile G, Wilson TG, Dwyer M, Ho M, National Comprehensive Cancer Network (NCCN), Clark PE, Agarwal N, Biagioli MC, Eisenberger MA, Greenberg RE, Herr HW, Inman BA, Kuban DA, Kuzel TM, Lele SM, Michalski J, Pagliaro LC, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Richie JPBladder cancer.J Natl Compr Canc Netw 11 446-75 4/1/2013
  • D'Souza AM, Pohar KS, Arif T, Geyer S, Zynger DLRetrospective analysis of survival in muscle-invasive bladder cancer: impact of pT classification, node status, lymphovascular invasion, and neoadjuvant chemotherapy.Virchows Arch 461 467-74 10/1/2012

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu